BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 26755586)

  • 1. Neuregulin1 displayed on motor axons regulates terminal Schwann cell-mediated synapse elimination at developing neuromuscular junctions.
    Lee YI; Li Y; Mikesh M; Smith I; Nave KA; Schwab MH; Thompson WJ
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):E479-87. PubMed ID: 26755586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking skeletal muscle DHPRs/Ryr1 prevents neuromuscular synapse loss in mutant mice deficient in type III Neuregulin 1 (CRD-Nrg1).
    Liu Y; Sugiura Y; Chen F; Lee KF; Ye Q; Lin W
    PLoS Genet; 2019 Mar; 15(3):e1007857. PubMed ID: 30870432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nerve terminal withdrawal from rat neuromuscular junctions induced by neuregulin and Schwann cells.
    Trachtenberg JT; Thompson WJ
    J Neurosci; 1997 Aug; 17(16):6243-55. PubMed ID: 9236235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of glial neurofascin155 delays developmental synapse elimination at the neuromuscular junction.
    Roche SL; Sherman DL; Dissanayake K; Soucy G; Desmazieres A; Lamont DJ; Peles E; Julien JP; Wishart TM; Ribchester RR; Brophy PJ; Gillingwater TH
    J Neurosci; 2014 Sep; 34(38):12904-18. PubMed ID: 25232125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminal Schwann cells participate in neuromuscular synapse remodeling during reinnervation following nerve injury.
    Kang H; Tian L; Mikesh M; Lichtman JW; Thompson WJ
    J Neurosci; 2014 Apr; 34(18):6323-33. PubMed ID: 24790203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuregulin-1 controls an endogenous repair mechanism after spinal cord injury.
    Bartus K; Galino J; James ND; Hernandez-Miranda LR; Dawes JM; Fricker FR; Garratt AN; McMahon SB; Ramer MS; Birchmeier C; Bennett DL; Bradbury EJ
    Brain; 2016 May; 139(Pt 5):1394-416. PubMed ID: 26993800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synapse elimination from the mouse neuromuscular junction in vitro: a non-Hebbian activity-dependent process.
    Nelson PG; Fields RD; Yu C; Liu Y
    J Neurobiol; 1993 Nov; 24(11):1517-30. PubMed ID: 8283186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal neuregulin-1 regulates myelin sheath thickness.
    Michailov GV; Sereda MW; Brinkmann BG; Fischer TM; Haug B; Birchmeier C; Role L; Lai C; Schwab MH; Nave KA
    Science; 2004 Apr; 304(5671):700-3. PubMed ID: 15044753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schwann Cells in Neuromuscular Junction Formation and Maintenance.
    Barik A; Li L; Sathyamurthy A; Xiong WC; Mei L
    J Neurosci; 2016 Sep; 36(38):9770-81. PubMed ID: 27656017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postnatal development of Schwann cells at neuromuscular junctions, with special reference to synapse elimination.
    Hirata K; Zhou C; Nakamura K; Kawabuchi M
    J Neurocytol; 1997 Dec; 26(12):799-809. PubMed ID: 9482156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuregulin1 fine-tunes pre-, post-, and perisynaptic neuromuscular junction development.
    Wang J; Song F; Loeb JA
    Dev Dyn; 2017 May; 246(5):368-380. PubMed ID: 28245533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axon withdrawal during synapse elimination at the neuromuscular junction is accompanied by disassembly of the postsynaptic specialization and withdrawal of Schwann cell processes.
    Culican SM; Nelson CC; Lichtman JW
    J Neurosci; 1998 Jul; 18(13):4953-65. PubMed ID: 9634561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of peripheral nerve myelination by the beta-secretase BACE1.
    Willem M; Garratt AN; Novak B; Citron M; Kaufmann S; Rittger A; DeStrooper B; Saftig P; Birchmeier C; Haass C
    Science; 2006 Oct; 314(5799):664-6. PubMed ID: 16990514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terminal Schwann cells participate in the competition underlying neuromuscular synapse elimination.
    Smith IW; Mikesh M; Lee Yi; Thompson WJ
    J Neurosci; 2013 Nov; 33(45):17724-36. PubMed ID: 24198364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terminal Schwann cell and vacant site mediated synapse elimination at developing neuromuscular junctions.
    Jung JH; Smith I; Mikesh M
    Sci Rep; 2019 Dec; 9(1):18594. PubMed ID: 31819113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classical major histocompatibility complex class I molecules in motoneurons: new actors at the neuromuscular junction.
    Thams S; Brodin P; Plantman S; Saxelin R; Kärre K; Cullheim S
    J Neurosci; 2009 Oct; 29(43):13503-15. PubMed ID: 19864563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo observations of pre- and postsynaptic changes during the transition from multiple to single innervation at developing neuromuscular junctions.
    Balice-Gordon RJ; Lichtman JW
    J Neurosci; 1993 Feb; 13(2):834-55. PubMed ID: 8426240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asynchronous synapse elimination in neonatal motor units: studies using GFP transgenic mice.
    Keller-Peck CR; Walsh MK; Gan WB; Feng G; Sanes JR; Lichtman JW
    Neuron; 2001 Aug; 31(3):381-94. PubMed ID: 11516396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synapses form in skeletal muscles lacking neuregulin receptors.
    Escher P; Lacazette E; Courtet M; Blindenbacher A; Landmann L; Bezakova G; Lloyd KC; Mueller U; Brenner HR
    Science; 2005 Jun; 308(5730):1920-3. PubMed ID: 15976301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synapse-glia interactions are governed by synaptic and intrinsic glial properties.
    Rousse I; St-Amour A; Darabid H; Robitaille R
    Neuroscience; 2010 May; 167(3):621-32. PubMed ID: 20188148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.